NFE2L2 and colorectal carcinoma: Keap1/Nrf2 expression levels were abnormally expressed in the majority of CRC patient tumor samples, such as reduced expression of Keap1, Keap1 mutation or increased accumulation of Nrf2 in cell nucleus in tumor tissues [10].